ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
3D Bioprinted Blood-Brain-Tumor Barrier Spheroid-Based In Situ Evaluation of Anticancer Compounds Against Glioblastoma: ROS-Producing Ruthenium as a Potential Therapeutic Candidate.
Hyunjung Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.